BioSpace News Archive

Formula Shortage Highlights Supply Chain Concerns Facing Pharma Industry

The crisis caused by the shutdown of one plant is a stark reminder of critical supply chain issues in other sectors, including the pharmaceutical industry.

May 23, 2022
·
2 min read
·
Alex Keown
Drug Development

ASCO, ACCC Join Forces to Increase Diversity in Cancer Clinical Trials

The American Society of Clinical Oncology and the Association of Community Cancer Centers are combining their efforts to increase racial and ethnic diversity in clinical trials.

May 23, 2022
·
6 min read
·
Geoff Herman
Drug Development

Elicio Touts “Huge Potential” for Cancer Vaccine Following Preclinical Data

Elicio Therapeutics published data on the preprint server bioRxiv, describing preclinical research into its cancer vaccine that shows a lot of promise.

May 23, 2022
·
3 min read
·
Mark Terry
Business

Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration

Vir Biotechnology terminated a two-year-old COVID-19-related antibody collaboration with Wuxi Biologics that included sotrovimab, which lost EUA in the U.S. earlier this year.

May 23, 2022
·
2 min read
·
Alex Keown
Drug Development

Alnylam Reports More Positive Data as Vutrisiran Awaits July FDA Date

Alnylam Pharmaceuticals shared 18-month results from its phase III Helios-A clinical study demonstrating that vutrisiran improves clinical cardiac symptoms in patients with hATTR.

May 23, 2022
·
3 min read
·
Jazmine Colatriano M.S.
Drug Development

Regeneron’s Evinacumab Fights Ultra-Rare Form of High Cholesterol in Kids

Regeneron Pharmaceuticals shared positive results from its Phase III trial of an evinacumab for children with homozygous familial hypercholesterolemia.

May 23, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Innoviva Snaps Up Remaining Entasis Shares, High Potential Assets

Burlingame, CA-based Innoviva is buying all of Waltham, MA-based Entasis Therapeutics’ available shares at $2.20 per share. Currently, Innoviva owns about 60% of Entasis’ outstanding shares.

May 23, 2022
·
3 min read
·
Mark Terry
Drug Development

Study: Lower Body Weight Related to Longer-Lasting COVID-19 Vaccine Immunity

A small research study published in Jama shows people with a lower body mass index (BMI) tended to maintain immunity against COVID-19 longer.

May 23, 2022
·
3 min read
·
Mark Terry
Drug Development

Cytokinetics, Seagen, Concert and Idorsia Begin Week with Trial Wins

Several biopharma companies are opening the week with positive clinical trial news. Read on for updates from Cytokinetics, Concert Pharmaceuticals, Idorsia and Seagen.

May 23, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Third Dose Appears to Be the Charm for Pfizer-BioNTech Vaccine in Young Kids

Based on topline data, Pfizer stated that three doses of the COVID-19 vaccine met all immunobridging criteria required for EUA. The FDA’s advisory committee will meet June 15 to discuss the matter.

May 23, 2022
·
2 min read
·
Hayley Shasteen